I say this in the least pumpy way possible too, if it's true that cardioprotective qualities of Zantrene has the same market potential as FTO why shouldn't our share price be double what it is now? (Less than when we received the cardioprotective news)
The only positive I can find is that it's giving me more time to get friends and family in as shareholders.
I say this in the least pumpy way possible too, if it's true...
-
- There are more pages in this discussion • 11,328 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.84 |
Change
-0.025(1.34%) |
Mkt cap ! $313.3M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.91 | $1.81 | $257.6K | 138.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 26825 | $1.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.90 | 759 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |